These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 23633352
1. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. Beer H, Southern KW, Swift AC. Cochrane Database Syst Rev; 2013 Apr 30; (4):CD008253. PubMed ID: 23633352 [Abstract] [Full Text] [Related]
2. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. Beer H, Southern KW, Swift AC. Cochrane Database Syst Rev; 2015 Jun 22; 2015(6):CD008253. PubMed ID: 26098667 [Abstract] [Full Text] [Related]
7. Inhaled corticosteroids for cystic fibrosis. Balfour-Lynn IM, Welch K. Cochrane Database Syst Rev; 2014 Oct 09; (10):CD001915. PubMed ID: 25300165 [Abstract] [Full Text] [Related]
8. Inhaled corticosteroids for cystic fibrosis. Balfour-Lynn IM, Welch K. Cochrane Database Syst Rev; 2016 Aug 23; (8):CD001915. PubMed ID: 27552284 [Abstract] [Full Text] [Related]
9. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. Elphick HE, Scott A. Cochrane Database Syst Rev; 2016 Dec 01; 12(12):CD002007. PubMed ID: 27907224 [Abstract] [Full Text] [Related]
10. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Elphick HE, Tan A. Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002007. PubMed ID: 15846627 [Abstract] [Full Text] [Related]
11. Oral steroids for nasal polyps. Patiar S, Reece P. Cochrane Database Syst Rev; 2007 Jan 24; (1):CD005232. PubMed ID: 17253548 [Abstract] [Full Text] [Related]
12. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Ng SM, Franchini AJ. Cochrane Database Syst Rev; 2014 Jul 13; (7):CD003424. PubMed ID: 25019293 [Abstract] [Full Text] [Related]
13. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Elphick HE, Jahnke N. Cochrane Database Syst Rev; 2014 Apr 30; (4):CD002007. PubMed ID: 24788768 [Abstract] [Full Text] [Related]
15. Oscillating devices for airway clearance in people with cystic fibrosis. Morrison L, Innes S. Cochrane Database Syst Rev; 2017 May 04; 5(5):CD006842. PubMed ID: 28471492 [Abstract] [Full Text] [Related]
16. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Wood DM, Smyth AR. Cochrane Database Syst Rev; 2006 Jan 25; (1):CD004197. PubMed ID: 16437476 [Abstract] [Full Text] [Related]
17. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Somaraju UR, Solis-Moya A. Cochrane Database Syst Rev; 2014 Oct 13; (10):CD008227. PubMed ID: 25310479 [Abstract] [Full Text] [Related]
18. Oral anti-pseudomonal antibiotics for cystic fibrosis. Remmington T, Jahnke N, Harkensee C. Cochrane Database Syst Rev; 2013 Oct 29; (10):CD005405. PubMed ID: 24170644 [Abstract] [Full Text] [Related]
19. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Patel S, Sinha IP, Dwan K, Echevarria C, Schechter M, Southern KW. Cochrane Database Syst Rev; 2015 Mar 26; (3):CD009841. PubMed ID: 25811419 [Abstract] [Full Text] [Related]
20. Oscillating devices for airway clearance in people with cystic fibrosis. Morrison L, Agnew J. Cochrane Database Syst Rev; 2014 Jul 20; (7):CD006842. PubMed ID: 25038719 [Abstract] [Full Text] [Related] Page: [Next] [New Search]